Navigation Links
Biovista und DART Therapeutics nehmen Zusammenarbeit auf, um auf Duchenne-Muskeldystrophie abzielende Medikamente neu zu positionieren
Date:3/26/2013

28;higkeiten bei der Neupositionierung von Medikamenten", sagte Aris Persidis, Präsident von Biovista. "Wir glauben, dass diese Art von Kooperationen bezeichnend für Interessengruppen ist, die sich darum bemühen, auf neuartige Weisen Therapien zu entwickeln, die direkter ihre spezifischen Bedürfnisse ansprechen, und wir freuen uns auf die Zusammenarbeit mit DART Therapeutics."

Über Biovista

Biovista ist ein nicht börsennotiertes Biotechnologie-Unternehmen, das sich auf die Ermittlung neuer Anwendungsbereiche für bereits zugelassene Medikamente sowie die Erstellung von Profilen zu ihren Nebenwirkungen spezialisiert hat, die über das entsprechende Wirkprinzip ermittelt werden. Biovista entwickelt eine eigene Produktpipeline von Medikamenten für das ZNS, die Onkologie sowie Autoimmun- und seltene Krankheiten. Biovista arbeitet mit biopharmazeutischen Unternehmen an der Erweiterung von Indikationsbereichen und der Risikobereinigung ihrer Portfolios zusammen. Sie unterstützt zudem die FDA bei der Vorhersage von Nebenwirkungen und Interessengruppen von Patienten bei der Neupositionierung von Medikamenten. (http://www.biovista.com).

Über DART Therapeutics

DART Therapeutics Inc. aus Cambridge, Massachusetts, ist ein Biotechnologie-Unternehmen, da ein neues Modell für Medikamentenentwicklung auf seltene pädiatrische neuromuskuläre Krankheiten anwendet. Beim DART-Modell haben sich Patientenstiftungen und Biotechnologie-Industrie-Veteranen zusammengeschlossen, um Einfluss auf ein zentrales Problem bei seltenen Krankheiten zu nehmen: die rasche Therapie-Entwicklung. DART konzentriert sich auf DMD, eine tödliche neuromuskuläre Erkrankung, für die es keine wirksame Behandlung gibt. (http://www.dartrx.com).

Kontakte:
Biovista, Inc.
Aris Persidis
+1
'/>"/>

SOURCE Biovista, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... group at the Institute for Molecular Medicine Finland ... has developed a novel "man and machine" decision ... diagnostic aid was described in PLOS One ... is based on computer vision algorithms similar to ... visualization of only the diagnostically most relevant areas. ...
(Date:8/21/2014)... His Majesty Willem-Alexander, King of the Netherlands ... His Majesty Willem-Alexander, King of the Netherlands, has announced ... POET-DSM Advanced Biofuels’ Project LIBERTY cellulosic ethanol plant in ... will take part in the Grand Opening Ceremony to ... p.m. and tour the plant. POET-DSM is a joint ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 Mathematic ... at Harvard University , and funded by the ... aggressive cells within tumors can be visually identified for elimination. ... tumor,s growth. The study, which shows a topological map of ... needed time in cancer research, for while tumor cells can ...
(Date:8/21/2014)... August 21, 2014 Pursuit Solutions ... optimization technology and services for Life Sciences sales ... Pharma’s Use of New Commercial Sales Models” by ... Analytics. , The article examines some innovative models ... are being tested in the pharmaceutical market. Robinson ...
Breaking Biology Technology:A novel 'man and machine' decision support system makes malaria diagnostics more effective 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2
... (a wholly-owned subsidiary of AVANT,Immunotherapeutics)(Nasdaq: AVAN ) ... developed for the treatment of Glioblastoma,Multiforme (GBM), will ... the 44th,Annual Meeting of the American Society of ... at McCormick Place in Chicago from May 30 ...
... Digirad Corporation,(Nasdaq: DRAD ), a leading provider ... offices, hospitals and imaging centers, today,announced the signing ... School of Medicine in Baltimore, Md., Under ... available to read,diagnostic images for primary care physicians, ...
... Partners released our,2008 studies of executive compensation in the ... ( http://www.dolmatconnell.com ),today and issued the below press release ... some very interesting findings, summarized in the press,release, that ... If,you would like to discuss any of the findings ...
Cached Biology Technology:AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting 2AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting 3Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 2Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 3Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 4DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance 2DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance 3
(Date:8/22/2014)... the bees. But that old expression leaves out ... process for flowering plants is particularly complex and ... reproductive cells. New research from an international team ... Carnegie,s Wolf Frommer, David Ehrhardt, and Guido Grossmann ... guides flowering plant fertilization. It is published in ...
(Date:8/21/2014)... Ind. -- A new study of American singles ... men have the highest orgasm rates. On average, ... with their sexual orientation making little difference. For ... average, women experience orgasm 62.9 percent of the ... and this pattern varies with women,s sexual orientation, ...
(Date:8/21/2014)... they are the ultimate source of all organic matter ... on algae, too, to suck up climate-warming carbon dioxide ... of the ocean. Now, by using a combination of ... that viruses infecting those algae are driving the life-and-death ... stays essentially the same, and this has important implications ...
Breaking Biology News(10 mins):Calcium and reproduction go together 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4Viruses take down massive algal blooms, with big implications for climate 2
... researchers have discovered how malaria parasites persuade red blood cells ... parasites. The malaria marauders hack into the red cell's signaling ... spring open the door to the cell. But researchers have ... signal to prevent the parasite from breaking in. ...
... human mothers are probably happy that they typically have one, ... low birth numbers combined with competition often spelled extinction. , ... hard for them to respond to rapid perturbations in the ... department head at Penn State. "Through time we see ...
... very small. , Nano small. , A Michigan State ... polymer films from buckling and wrinkling. It's a new solution ... in new technology such as electronic monitors. , ... seems crossed with science fiction ?from microdermabrasians to lasers ...
Cached Biology News:Researchers discover surprising drug that blocks malaria 2Birth rate, competition are major players in hominid extinctions 2Birth rate, competition are major players in hominid extinctions 3Nanotechnology shows promise as next wrinkle fighter 2
... A high quality source of ... the enzymatic digestion of casein. It ... fermentations and has been used in ... casein, pancreatic digest For microbiology pH6.8 ...
... Human Raji cells were cultured in RPMI 1640 ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... mini incubation trays are disposable ... screen antigens that have been ... tray has eight 10.5 cm ... accommodate strips cut from blotted ...
Biology Products: